Compare VVOS & PRSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VVOS | PRSO |
|---|---|---|
| Founded | 2016 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.7M | 7.8M |
| IPO Year | 2020 | 2000 |
| Metric | VVOS | PRSO |
|---|---|---|
| Price | $0.59 | $0.96 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | $2.75 | ★ $3.00 |
| AVG Volume (30 Days) | 184.8K | ★ 2.5M |
| Earning Date | 04-15-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 6.76 | ★ 81.23 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $17,443,000.00 | $14,573,000.00 |
| Revenue This Year | $69.66 | $18.48 |
| Revenue Next Year | $48.38 | $53.57 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 16.05 | 5.99 |
| 52 Week Low | $0.58 | $0.77 |
| 52 Week High | $7.40 | $2.37 |
| Indicator | VVOS | PRSO |
|---|---|---|
| Relative Strength Index (RSI) | 29.38 | 46.95 |
| Support Level | N/A | $0.84 |
| Resistance Level | $1.50 | $0.99 |
| Average True Range (ATR) | 0.07 | 0.10 |
| MACD | 0.00 | -0.00 |
| Stochastic Oscillator | 9.00 | 5.96 |
Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.
Peraso Inc is a fabless semiconductor company focused on the development and sale of: i) millimeter wavelength wireless technology, or mmWave, semiconductor devices and antenna modules based on its proprietary semiconductor devices and ii) performance of non-recurring engineering, or NRE, services and licensing of intellectual property, or IP. The company's primary focus is the development of mmWave, which is generally described as the frequency band from 24 Gigahertz, or GHz, to 300 GHz. Geographically the company generates revenue from the United States, Hong Kong, Taiwan, and the Rest of the World.